Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumor × pemigatinib × Clear all

Sponsor

Conditions

Acrocephalosyndactylia 5 Carcinoma, Transitional Cell 3 Neoplasm Metastasis 2 Cholangiocarcinoma 2 Recurrence 1 Oligodendroglioma 1 Neoplasms, Unknown Primary 1 Myeloproliferative Disorders 1 Glioma 1 Glioblastoma 1 Eosinophilia 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignancies 1

Interventions

pertuzumab 2 durvalumab 2 Paclitaxel 2 Nivolumab 2 Docetaxel 2 Capecitabine 2 ulocuplumab 1 tremelimumab 1 tazarotene 1 talazoparib 1 romiplostim 1 pexidartinib 1 pembrolizumab 1 pamiparib 1 magrolimab 1 entrectinib 1 cobimetinib 1 atezolizumab 1 Sunitinib 1 Rifampin 1 Radiosurgery 1 Midazolam 1 LY3022855 1 LY2510924 1 Itraconazole 1 Irinotecan 1 Ipilimumab 1 Dextromethorphan 1 Carboplatin 1 CH5183284 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡